ONCOLOGY Key injectables: Cisplatin, Carboplatin, Daratumumab-SC, Rituximab-SC, G-CSF agents (Neulasta/Zarxio), Leuprolide Hydration mandate: Labels require aggressive pre/post-infusion hydration to prevent nephrotoxicity — rarely monitored at home.
Key injectables: Krystexxa (pegloticase) ~$30K/series; Canakinumab (Ilaris) SC for acute flares Hydration mandate: Dehydration is the #1 trigger for breakthrough flares. At $30K/series, pharma has strong incentive to protect efficacy.
Key injectables: Darbepoetin alfa (Aranesp), Epoetin alfa (Epogen), Feraheme IV iron, Parsabiv Hydration mandate: CKD patients require precise daily fluid targets. Water.io monitors against physician-prescribed goals.